Research projects conducted by the German Breast Group
The German Breast Group conducts research into breast cancer, developing and implementing its own study concepts.
With the help of additional scientific research projects, we strive to gain further insights into this disease.
Research News
-
24.05.2022 Ovarian Toxicity Assessment
In a paper in "The Breast" we discuss the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials.
-
23.05.2022 Ergebnisse zur Brustkrebs in der Schwangerschaft
Neue Daten zum Überleben von Brustkrebspatientinnen mit Chemotherapie während der Schwangerschaft
-
12.05.2022 GBG Research at ASCO 2022
We are happy to present our research at the ASCO Annual meeting June 2022.
-
30.04.2022 April 2022: Adjuvant pertuzumab significantly improved invasive disease-free survival for HER2-positive, N-positive early breast cancer in the APHINITY trial
We are pleased to inform you that a STEPP analysis of the updated data from the APHINITY trial has been published in European Journal of Cancer
-
31.03.2022 March 2022: Long-term outcomes from the BrighTNess trial support inclusion of carboplatin in neoadjuvant chemotherapy for early-stage TNBC.
We are pleased to inform you that 4-year follow-up data from the BrighTNess trial has been published in Annals of Oncology.
Paper of the month
Every month, we present an interesting paper.
-
18.11.2022 Desiree: dose escalation of everolimus published
We are proud to inform you that our article A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE; GBG 86) is now available online.